Centessa Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
Centessa Pharmaceuticals has raised $300M across 1 funding round on record, the most recent a Post-IPO Debt of $300M announced in Oct 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Centessa Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Centessa Pharmaceuticals Funding Rounds
Centessa Pharmaceuticals Founders and Leadership Team
Contact details for the Centessa Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Centessa Pharmaceuticals Funding Compared to Other Biotechnology Startups
Centessa Pharmaceuticals' latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Centessa Pharmaceuticals in Biotechnology and Cambridge
Companies Similar to Centessa Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Centessa Pharmaceuticals Funding FAQs
What does Centessa Pharmaceuticals do?
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
How much funding has Centessa Pharmaceuticals raised?
Centessa Pharmaceuticals has raised $300M across 1 round on record. The most recent is a Post-IPO Debt of $300M announced in Oct 2021.
When did Centessa Pharmaceuticals last raise funding?
Centessa Pharmaceuticals' most recent funding round on record is a Post-IPO Debt of $300M, announced in Oct 2021.
Who is the CEO of Centessa Pharmaceuticals?
Saurabh Saha is listed as CEO at Centessa Pharmaceuticals.
Where is Centessa Pharmaceuticals headquartered?
Centessa Pharmaceuticals is based in Cambridge, Massachusetts, United States.
How many employees does Centessa Pharmaceuticals have?
Centessa Pharmaceuticals is in the 11-50 employee band.
How does Centessa Pharmaceuticals' funding compare to other Biotechnology startups?
Centessa Pharmaceuticals' latest round of $300M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Centessa Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Centessa Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.